P ulmonary arterial hypertension (PAH) results from progressive adverse remodeling of the distal pulmonary arteries. Although the right ventricle (RV) initially compensates in part by developing muscle wall hypertrophy, a significant proportion of patients develop progressive RV failure and ultimately death.
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June 14, 2016 or under stress. Although direct measurement of pressurevolume (PV) relations remains the gold standard for cardiac hemodynamics, 13 such data are scant for the RV, and not yet reported for stress conditions. Accordingly, this study prospectively assessed RV functional reserve in subjects with IPAH and SSc-PAH referred for RHC. We measured hemodynamic responses to 2 stressors-incremental atrial pacing and supine bicycle cardiopulmonary exercise testing-while concurrently measuring continuous RV PV relationships. We hypothesized that unlike IPAH, SSc-PAH has depressed RV systolic and diastolic reserve, forcing maladaptive compensatory mechanisms during physiological stress that could contribute to its poor prognosis.
Methods

Study Subjects
We prospectively enrolled 43 patients from November 2012 to October 2015 at the Johns Hopkins Hospital referred for RHC for the diagnosis or management of PAH. The research protocol was approved by the Johns Hopkins Medical Institutions Institutional Review Board, and informed consent was obtained in all patients. SSc patients met recently updated 2013 American College of Rheumatology/European League Against Rheumatism diagnostic criteria.
14 PAH was diagnosed by a mean pulmonary artery pressure ≥25 mm Hg and pulmonary vascular resistance >3 Wood units with pulmonary artery wedge pressure ≤15 mm Hg during RHC. 15 IPAH patients had all known causes of PAH excluded. 15 Patients were diagnosed with SSc-PAH if they met criteria for SSc and PAH and had secondary causes of pulmonary hypertension (PH) such as interstitial lung disease (based on radiographic evidence and forced vital capacity <70%) or left-sided heart failure (based on echocardiography and RHC) excluded. Comparisons of RV functional reserve were made between IPAH and SSc-PAH subjects (n=24); additional regression analyses were made in an expanded cohort that also included a normal and several SSc subjects without PAH, and SSc patients with secondary PH, as well (n=33).
Study Design
Baseline clinical characteristics were obtained from standardized clinic data obtained by PH physicians. All reported laboratory data were obtained at the time of this visit or within 6 months previously. Patients underwent cardiac MRI (CMR) within 5 hours before RHC. After standard RHC, the internal jugular introducer sheath was exchanged for a dual-entry 9F sheath (#406333, St. Jude's Medical, St. Paul, MN) to enable simultaneous placement of a 5F PV catheter (SPC-570-2, Millar Instruments, Houston, TX), and either a bipolar pacing wire (2.8F, D98500H, Edwards, Irvine, CA, or 4F, #401994, St. Jude's Medical, St. Paul, MN) or 4F balloon-tipped pulmonary artery (PA) wedge catheter (AI-07122, Teleflex, Morrisville, NC).
The PV catheter was advanced under fluoroscopic guidance until its pigtail tip reached the RV apex. Signals generated from individual electrode pairs on the catheter were examined, and those in phase and consistent with an intracavitary position were summed to generate total volume. Steady-state data were measured at end-expiration and during a multibeat decline in RV end-diastolic filling during a Valsalva maneuver, as previously described and validated. 6 After basal PV data were obtained, a bipolar pacing wire was positioned in the right atrium and pacing capture confirmed. Incremental atrial pacing starting at ≈80 to 90 min -1 (slightly above normal sinus rate) was then increased in steps of 20 min -1 to a peak of 140 to 150 min -1 or rate when second-degree atrioventricular block (Mobitz I) was observed. Data were recorded at end-expiration after 1 minute of pacing, and during the first 15 seconds on acute cessation of pacing, to assess contractility potentiation and its rate of decay. 16 The pacing catheter was then replaced by the balloontipped PA wedge catheter, and subjects positioned into a supine bicycle ergometer. A nose clip and mouthpiece (Innocor, Innovision, Denmark) were placed to measure continuous oxygen consumption. Subjects then underwent bicycle exercise using a modified protocol beginning at 15 W during stage 1, increasing in 10-W increments per 2-minute stage until symptom-limited maximum effort was achieved. Pulmonary artery pressures, gas exchange, and PV data were continuously recorded.
Data Analysis
The RV volume signal was calibrated to resting RV volume measurements obtained by same-day CMR. End-systolic PV points were determined from a set of loops with varying preload volumes during phase 2 of the Valsalva maneuver, and fit by perpendicular regression using an iterative algorithm to derive the slope (end-systolic elastance, E es ) of the end-systolic PV relationship. This slope was then applied to the resting PV loop to determine the x intercept (V 0 ) of the end-systolic PV relationship, as described. 6 Effective arterial elastance (E a ) was determined by dividing end-systolic pressure by stroke volume. RV-PA coupling was assessed by the ratio of E es /E a .
During pacing, high-fidelity RV pressure tracings from each paced heart rate (HR) were analyzed for contractile force (maximum of the derivative of pressure with respect to time, or dP/dt max ) and dP/ dt max normalized to the instantaneous pressure developed (dP/dt max / IP). After cessation of pacing at each HR, the dP/dt max of the 5 to 6 subsequent beats were measured while ensuring relatively equivalent volumes between beats. RV dP/dt max decayed in a geometric fashion similar to that previously described in the left ventricle (LV). 16 Each beat was normalized to steady-state dP/dt max ; normalized values were then plotted against that of the subsequent beat to yield a linear decay, with the slope being the recirculation fraction.
For exercise data, signal-averaged representative PV loops were obtained from rest (with subject's feet elevated in pedals, subsequently referred to as stage 0) and each stage of exercise, as well. All subjects exercised through at least stage 2 (25 W, 4 minutes), and primary analysis was based on data assessed at this matched workload. Resting V 0 was used to calculate E es for subsequent PV loops. 17, 18 Data were analyzed with custom developed software (WinPVAN-3.5.10).
Statistical Methods
Results are presented as mean±standard error of the mean unless otherwise indicated. Given sample sizes, simple comparisons of continuous variables were performed using the Wilcoxon-Mann-Whitney test, whereas the Fisher exact test was used to compare categorical variables. For pacing and exercise analyses, repeated-measures analysis of variance was performed using the independent variables of disease group, pacing or exercise stage, and the disease-stage interaction term (HRs were sorted into 4 pacing bins). The Greenhouse-Geiser correction was applied to repeated variable P values if sphericity was violated. Pearson correlation coefficients were used to determine correlations between continuous variables. Regression analyses were performed to assess the significance of any correlations or regression coefficient comparisons. Log transformations were done as necessary to normalize distributions for regression. A P value of <0.05 (2-sided) was considered significant throughout. Graphics were created and statistical analyses were performed by using commercially available software (SigmaPlot-11.0, Systat, San Jose, CA; Stata-11, StataCorp, College Station, TX).
Results
Study Population
Of the 43 patients enrolled, 28 satisfied diagnostic criteria for either IPAH or SSc-PAH, and PV catheter data were obtained from 24 (IPAH, n=9; SSc-PAH, n=15; 2 from each group were excluded for safety or technical reasons). Another 15 patients had alternate diagnoses; of these, data were obtained from 13, whereas 2 were excluded for safety or technical reasons ( Figure I in Heart Rate-Dependent Change in Contractility, Relaxation, and Calcium Handling Figure 1A shows contractile function assessed by dP/dt max and the less load-sensitive dP/dt max /IP, each as a function of incremental atrial pacing rate. Both parameters rose with faster HRs in both groups (P<0.001), but the force-frequency response was blunted in SSc-PAH subjects (P=0.002 and P=0.03, respectively, for interaction terms). Figure 1B shows individual changes and group differences in RV preload (enddiastolic volume and pressure) between lowest and fastest HR. End-diastolic volume declined in both groups (P<0.01), whereas end-diastolic pressure fell significantly in IPAH only (P<0.001).
A major contributor to the force-frequency relation is recycling of calcium into and out of the sarcoplasmic reticulum. 20, 21 This can be assessed in vivo by measuring the geometric rate of decay in contractile potentiation following abrupt cessation of atrial pacing (Figure 2A) . Plotting dP/dt max (normalized to steady state) for beat n+1 versus beat n after stopping pacing yields a linear plot, with the slope being the decay constant, known as recirculation fraction (0.47 or 47% in example, Figure 2B ). IPAH patients had a mean recirculation fraction (RF) of 0.50±0.05, similar to that of the normal LV. By contrast, RF for the SSc-PAH group was 0.32±0.05 (P=0.039 versus IPAH, Figure 2C ), consistent with values previously reported for symptomatic LV hypertrophic disease 16 and LV systolic heart failure. Table 1 summarizes baseline functional capacity and metabolic data at peak exercise for both groups. There were no significant differences in baseline New York Heart Association functional class makeup or 6-minute walk distance between
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RV Functional Reserve and Volume Compensation During Exercise
Heart rate (min -1 ) Force-frequency response and diastolic relaxation. A, Contractility was assessed by dP/dt max and dP/dt max normalized to instantaneous pressure (dP/dt max /IP) developed with escalating pacing rates. * denotes significant difference between disease groups. # denotes significant difference in disease-pacing interaction (pacing effect). SSc-PAH showed diminished contractility and force-frequency response in comparison with IPAH. The interaction term between groups was significantly different for both dP/dt max (P=0.002) and dP/ dt max /IP (P=0.03). In addition, there was a significant disease group difference in dP/dt max /IP (P=0.006). B, RV end-diastolic volume (EDV) and pressure (EDP) were charted for each patient in each group. Mean values±SEM superimposed in bold. IPAH demonstrated decreases in EDP with pacing, whereas SSc-PAH subjects did not. IPAH indicates idiopathic pulmonary arterial hypertension; RV, right ventricle; SEM, standard error of the mean; and SSc-PAH, systemic sclerosis-associated pulmonary arterial hypertension. groups. At peak performance, IPAH subjects exercised nearly twice as long as SSc-PAH subjects (11.3±1.6 versus 6.1±0.8 minutes; P=0.009) and achieved greater maximum power (66±8 versus 36±4 W, P=0.004). There were concordant difference trends in peak Vo 2 max and ventilatory efficiency (Ve/ Vco 2 ratio), although these did not reach statistical significance. Both groups exerted equivalent effort as determined by the respiratory exchange ratio. Figure 3 displays representative PV loops from exercise stages 0 to 3 for both groups, and from an example patient with a normal RV and no PH, as well (loops from all patients for stage 0-2 are provided in Figure IIA and IIB in the online-only Data Supplement). With progressive exercise, IPAH patients displayed an upward and slight leftward shift of the end-systolic PV point (upper left corner of the loop), similar to but with less relative shift than the normal RV. By contrast, with SSc-PAH, PV loops shifted rightward reflecting RV dilatation.
Because group differences in peak performance could confound comparisons at peak exertion, statistical comparisons of exercise RV functional reserve between IPAH and SSc-PAH were made at matched, submaximal workloads (stage 0-2, 0-25 W). Summary data for E es , E a , and their ratio are shown ( Figure 4A ; Table 2 ) along with percent changes of each variable at stage 2 versus baseline ( Figure 4B ). E es rose in IPAH but was virtually unaltered in SSc-PAH (group difference P<0.001, interaction term P=0.042), whereas E a increased similarly in both groups. Thus, the E es /E a ratio declined slightly in SSc-PAH but remained steady in IPAH (group difference P<0.001, interaction term P=0.078).
The failure of contractile augmentation during exercise in SSc-PAH patients was offset in part by RV dilation. At the end of stage 2 of exercise, HR, stroke volume, and CO were similar between the 2 groups ( Figure IIIA in the online-only Data Supplement). Yet SSc-PAH patients maintained stroke volume by increasing RV preload, whereas IPAH patients did not dilate ( Figure 5A ; Table 2 ). Consequently, RV ejection fraction was preserved in IPAH, but trended lower in SSc-PAH subjects (P=0.056 at stage 2, Figure 5B ).
To ensure there was no systematic bias in stroke volume and CO calculations based on PV catheter data during exercise, we compared CO calculated by the calibrated catheter signal with that by direct Fick method. Both were correlated throughout 
Resting RV-PA Coupling Ratio Predicts RV Dilatation During Exercise
We found a significant correlation between resting RV-PA coupling (E es /E a , log transformed to yield a Gaussian distribution) and ventilator efficiency (Ve/Vco 2 ), a known correlate of RV functional reserve (r = -0.35; P=0.049, adjusted for age and sex, Figure 6A ). 23 To improve the generalizability of this analysis, we expanded the cohort to include subjects without PAH (total n=33). Ventilatory efficiency also correlated with other indices of RV load and function (Figure VIIA in the online-only Data Supplement) but not LV performance (Figure VIIB in the online-only Data Supplement), similar to other previously reported data. 23 We also tested for a correlation between resting coupling and exercise RV systolic pressure augmentation (which has been shown to predict mortality in PH 7 ), but did not observe such a correlation among our PH subjects ( Figure VIIC in the online-only Data Supplement).
Given the association between reduced RV-PA coupling and RV volume increase seen in SSc-PAH subjects during exercise (Figures 4 and 5) , we next tested whether coupling at rest predicted exercise-induced end-diastolic volume change in the larger cohort. Overall, there was indeed a moderate negative correlation between resting E es /E a (log transformed) and percent change in end-diastolic volume with exercise (r = -0.39; P=0.018, adjusted for age and sex, Figure 6B ).
Discussion
Comparing SSc-PAH to IPAH offers a unique opportunity to investigate deficient RV compensation in PAH, given the disproportionate rates of RV failure and death in SSc-PAH. 3, 4 Commonly used hemodynamic and imaging measures of resting RV function (eg, ejection fraction) have not adequately explained why patients with SSc-PAH are more vulnerable than those with IPAH. More recently, we showed that, although SSc-PAH subjects have similar pulmonary vascular load, their RV resting contractility is depressed. 6 However, the RV reserve response, perhaps more important, given its ability to aid in assessment and prognosis beyond resting function alone, was unknown in SSc-PAH in comparison with IPAH, and no previous study had determined this. Here, we used continuous PV analysis and show for the first time that, despite similar resting RV function, LV function, and overall chamber morphology, SSc-PAH subjects have markedly depressed RV functional reserve reflected by depressed force-frequency responsiveness, diminished contractile and diastolic reserve, and abnormal RV-PA coupling during exercise. This highlights the central role that intrinsic RV dysfunction plays in SSc-PAH. Furthermore, abnormal RV-PA coupling predicted abnormal RV dilation responses during exercise not only in the primary PAH comparison, but also in a larger cohort that included subjects without PAH.
RV Contractility and Diastolic Dysfunction and Its Relationship to Calcium Cycling
The force-frequency response (FFR) of the normal and diseased LV has been well studied, but very few analyses have been reported for the RV, and none specific to patients with PAH. [24] [25] [26] [27] The normal LV augments contractility by ≈100% (across a similar HR rise as was tested here), and this response is markedly depressed in patients with LV hypertrophic heart disease. 16 Data on the normal human RV FFR are lacking, but in the current study, the percent increase in RV FFR in IPAH was similar to that seen in the LV, 16 whereas in SSc-PAH, RV FFR was significantly blunted. In addition to FFR abnormalities, SSc-PAH patients also maintained higher end-diastolic pressures at faster rates despite the similar declines in RV preload, indicating inadequate diastolic relaxation during tachycardia and impaired RV diastolic reserve. This is intriguing because neither our previous study 6 nor the current one (Table II in the online-only Data Supplement) detected significant differences in resting RV diastolic function between IPAH and SSc-PAH.
A major regulator of the FFR is calcium cycling into and out of the sarcoplasmic reticulum, and sarcoplasmic reticulum dysfunction is a prominent contributor to a reduced FFR. The recirculation fraction is an admittedly indirect way to assess sarcoplasmic reticulum calcium cycling, but one that has proven useful when direct measurements are impossible-as in this in vivo human study. It has been validated by studies showing its modulation by activators and inhibitors of sarcoplasmic reticulum calcium uptake. 28, 29 In healthy humans, the RF is ≈50%, but declines to ≈35% in both human LV hypertrophy and systolic heart failure. 16, 22 Assessment of RF in the normal RV is limited to a few animal studies, 30, 31 with one also reporting LV values that were similar to those of the RV. 31 It is interesting that the RF in hypertrophied RVs of IPAH patients was also ≈50%, because this suggests that these RVs were still fairly compensated, consistent with their stronger FFR and exerciseinduced contractile reserve. RF in SSc-PAH patients was more like human LV failure, revealing greater underlying RV disease in this syndrome. These data suggest that drugs augmenting calcium cycling might prove beneficial to SSc-PAH patients.
RV Reserve and Compensatory Mechanisms During Exercise
Exercise stimulates the cardiovascular system to increase HR, augment RV and LV contractility, vasodilate peripheral skeletal vascular beds, and reduce venous capacitance. The latter offsets tachycardia-induced declines in diastolic filling as observed with pure atrial pacing. In the pulmonary vasculature, pulmonary vascular resistance typically declines despite a marked rise in CO; this in turn blunts the mean PA pressure increase seen by the RV. However, in PAH patients, pulmonary vascular resistance does not fall appropriately, and may even rise during exercise, increasing the load imposed on the RV. 32 This puts even more premium on the capacity of the RV to enhance contractility.
A few previous studies have compared RV functional reserve in PH patients with healthy controls. 11, 12 Spruijt et al 11 used single-beat E es estimates and concluded that, although contractility rose during exercise in healthy subjects, it failed to do so in a cohort of primarily PAH patients, thereby reducing RV-PA coupling. Claessen et al 12 exercised healthy controls and patients with chronic thromboembolic PH while imaging them using CMR. RV ejection fraction increased and RV endsystolic volume (ESV) decreased in controls while the opposite occurred in patients with chronic thromboembolic PH. In the present study, although we could not study truly healthy subjects given the nature of the protocol, it is likely that our IPAH patients had reduced reserve in comparison with a healthy group. It is noted that our IPAH results differ slightly from the Spruijt study, because, in our cohort, E es rose and RV-PA coupling was preserved with exercise. That is not to suggest that our IPAH subjects are healthy, because they demonstrate several abnormalities including a rise in pulmonary vascular resistance with exercise, diminished exercise endurance, peak oxygen consumption, and ventilatory efficiency, and less RV volume decline as observed in healthy subjects. 11, 12 The discrepancy between studies may relate to differences in the specific cohorts studied or the model-based calculation of RV E es used in the Spruijt study. The latter may underestimate E es in disease states such as PH or with dynamic changes in RV function. 
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SSc-PAH subjects demonstrated deficiencies in E es augmentation and RV-PA coupling during exercise in comparison with IPAH subjects. This correlated with a disparity in RV end-systolic and end-diastolic volume change with exercise. The discrepancy in volume change is consistent with a preload mechanism (ie, Frank-Starling effect, or heterometric adaption) being preferentially invoked in SSc-PAH when contractility (homeometric adaption) and afterload reduction mechanisms are blunted. A similar difference is observed in the LV with aging, where a decline in contractile and chronotropic reserve and increase in vascular stiffening (pulsatile load) is countered by greater LV dilation during exercise in elderly patients, enabling them to achieve a similar CO rise as in younger individuals. 36 The RV is also known to dilate with endurance training, although this is a chronic change to sustained exercise. 37 Transient ventricular dilation would not induce heart failure itself, although, in the RV in the setting of abnormal afterload (eg, PAH) and underlying myocardial defects, it is possible that this would only worsen maladaptive remodeling and outcomes in SSc-PAH.
The cause of the RV defect in SSc-PAH remains speculative. Interstitial fibrosis is observed in scleroderma myocardium, 38 although how this would relate to depressed contractile reserve per se is uncertain. For the cohort studied here, CMR analysis revealed no differences in delayed gadolinium uptake (to suggest a difference in RV fibrosis) or RV remodeling, aside from a difference in mid-RV free-wall thickness. Perhaps related, in a larger cohort, RV mass has been shown to be lower in SSc-PAH than in IPAH when adjusted for pulmonary vascular load. 39 Other possibilities include weakened myocyte contractility and abnormal angiogenesis in SSc; these are being studied in an ongoing investigation.
RV-PA coupling is a powerful, load-independent indicator of RV function in PH that detects RV dysfunction well before overt decreases in RV ejection fraction. 6, 35 Accurate clinical measurement of this ratio, however, has required invasive PV measurements. 13 Various noninvasive measurements of RV functional reserve have been proposed. Here, resting RV-PA coupling did not correlate with one such measurement-exercise change in RV systolic pressurealthough our PH cohort was small and unlike the relevant derivation cohorts. 7, 40 However, RV-PA coupling did correlate with ventilatory efficiency, which has been shown to correlate with RV functional reserve in conditions such as left-sided heart failure and PH. 23, 41 The correlation reported here between depressed RV-PA coupling and exerciseinduced RV dilation suggests a potentially new method to estimate coupling. With recent advances in 3-dimensional echocardiography or CMR during exercise, 12 ,42,43 one could assess RV dilatation with stress and use this as a surrogate . Exercise changes in contractility, afterload, and RV-PA coupling. A, E es , E a , and E es /E a were plotted for IPAH and SSc-PAH from exercise stage 0 to 2, whereas percent change at stage 2 normalized to baseline for each subject was graphed alongside by using dot and box plots (B). Despite similar increases in E a in both groups, IPAH subjects augmented E es , whereas SSc-PAH subjects did not. RV-PA coupling (E es /E a ) was maintained in the former but remained poor in the latter. * denotes significant difference between disease groups. # denotes significant difference in disease-exercise interaction (exercise effect). See Table 2 for P values. IPAH indicates idiopathic pulmonary arterial hypertension; RV-PA, right ventricularpulmonary artery; and SSc-PAH, systemic sclerosis-associated pulmonary arterial hypertension. for RV-PA coupling. Further work is needed to validate these findings in a range of healthy and diseased subjects and correlate them with clinical outcomes.
Study Limitations
The invasive nature of our protocol precluded analysis of healthy controls. We also had an unequal sample size between IPAH and SSc-PAH groups, which reflects some referral bias. However, we used nonparametric methods to deal with unequal variance as necessary. Our CMR protocol did not include T1 mapping to assess RV extracellular volume, which could have shed light on differences in fibrosis. The volume catheter provides an uncalibrated signal, and some uncertainty in calibration exists, particularly during maneuvers such as exercise. However, we found no systematic disparities between patient groups and comparisons of direct Fick measured and catheter-based CO, so calibration noise did not likely contribute to group disparities. Furthermore, volume calibration had no bearing on relative changes in volume or RV-PA coupling for any given subject.
Conclusion
Although patients with IPAH can mount significant improvement in contractility with both HR and exertional stress, patients with SSc-PAH cannot. This in part is likely related to depressed calcium cycling in the latter group. Likely as a consequence, RV end-diastolic and end-systolic volumes substantially increase in SSc-PAH patients during exercise, whereas these volumes are minimally altered in IPAH patients. The marked differences in RV functional reserve between groups despite similarities in pulmonary vascular load direct our focus toward innate RV pathology in SSc-PAH. Finally, a significant correlation existed between resting RV-PA uncoupling and increased chamber volumes during exercise, which held true even in a larger cohort. Assessing RV volume change with exercise may present a novel avenue for noninvasive assessment of RV-PA coupling.
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